Citation Impact
Citing Papers
Lifelong accumulation of bone in mice lacking Pten in osteoblasts
2007
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Structure of the PAPP-ABP5 complex reveals mechanism of substrate recognition
2022 StandoutNobel
Amino-Biphosphonate–Mediated MMP-9 Inhibition Breaks the Tumor-Bone Marrow Axis Responsible for Myeloid-Derived Suppressor Cell Expansion and Macrophage Infiltration in Tumor Stroma
2007
Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer.
2002
Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma
2000
Stepping out of the flow: capillary extravasation in cancer metastasis
2007
Vital Pulp Therapy with New Materials: New Directions and Treatment Perspectives—Permanent Teeth
2008
TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development
1999
Mineral trioxide aggregate pulpotomies
2006
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Breast cancer
2016 Standout
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis
2004
Osteoprotegerin Regulates Bone Formation through a Coupling Mechanism with Bone Resorption
2003
Paget disease of bone
2005
Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.
1998
Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic Acid
2002
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases
2004 Standout
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Mineral Trioxide Aggregate: A Comprehensive Literature Review—Part III: Clinical Applications, Drawbacks, and Mechanism of Action
2010 Standout
Cancer Metastasis: Building a Framework
2006 Standout
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
1998 Standout
TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation
2009 Standout
Bisphosphonates and the prevention of metastasis
2000
The biology and function of fibroblasts in cancer
2016 Standout
Coordinated regulation of myeloid cells by tumours
2012 Standout
Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
1996
Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial
2012
Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment
1998
Apoptosis in bone physiology and disease.
1997
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Osteoporosis: now and the future
2011 Standout
Bisphosphonates in prostate carcinoma
1997
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Estrogen promotes apoptosis of murine osteoclasts mediated by TGF–β
1996
Treatment of Postmenopausal Osteoporosis
1998
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
1999
Mineral Trioxide Aggregate but not Light-cure Mineral Trioxide Aggregate Stimulated Mineralization
2008
Mineral Trioxide Aggregate: A Comprehensive Literature Review—Part II: Leakage and Biocompatibility Investigations
2010
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Regulation of osteoclast activity
1999
Mineral trioxide aggregate: a review of the constituents and biological properties of the material
2006
Rescue of osteoclast function by transgenic expression of kinase-deficient Src insrc−/− mutant mice
1997 Nobel
Mineral trioxide aggregate material use in endodontic treatment: A review of the literature
2007
Macrophages in Tissue Repair, Regeneration, and Fibrosis
2016 Standout
Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression
2002
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
2009
A Prospective Clinical Study of Mineral Trioxide Aggregate for Partial Pulpotomy in Cariously Exposed Permanent Teeth
2006
Bisphosphonates Act Directly on the Osteoclast to Induce Caspase Cleavage of Mst1 Kinase during Apoptosis
1999
Emerging Biological Principles of Metastasis
2017 Standout
Osteoclast differentiation and activation
2003 StandoutNature
Effect of mineral trioxide aggregate on proliferation of cultured human dental pulp cells
2006
Bisphosphonates in cancer therapy
2007
The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey
2008 StandoutNobel
The evolving role of bisphosphonates
2001
The bone microenvironment in metastasis; what is special about bone?
2007
Resolution of Bisphosphonate-Associated Osteonecrosis of the Mandible: Possible Application for Intermittent Low-Dose Parathyroid Hormone [rhPTH(1-34)]
2007
TGFβ in Cancer
2008 Standout
The role of tumour–stromal interactions in modifying drug response: challenges and opportunities
2013
Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>
1998 Standout
Identification of apoptotic changes in osteocytes in normal and pathological human bone
1997
Metastasis to bone: causes, consequences and therapeutic opportunities
2002 Standout
Microenvironmental regulation of metastasis
2008 Standout
Macrophage plasticity and polarization: in vivo veritas
2012 Standout
Immunohistochemical Analysis of Nestin, Osteopontin, and Proliferating Cells in the Reparative Process of Exposed Dental Pulp Capped with Mineral Trioxide Aggregate
2008
Osteoclasts are required for bone tumors to grow and destroy bone
1998
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
2007 Standout
Transmembrane crosstalk between the extracellular matrix and the cytoskeleton
2001 Standout
Mechanisms of Bone Metastasis
2004 Standout
Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain
2005 StandoutNobel
Unoccupied αvβ3Integrin Regulates Osteoclast Apoptosis by Transmitting a Positive Death Signal
2004
Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption.
1998
Bisphosphonates: mechanisms of action.
1996
Maturogenesis of a cariously exposed immature permanent tooth using MTA for direct pulp capping: a case report
2006
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
2000 Standout
Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim
2003
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Modulation of prostate cancer growth in bone microenvironments
2003
The BCL-2 protein family: opposing activities that mediate cell death
2007 Standout
Direct Pulp Capping With Mineral Trioxide Aggregate
2008
Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice
1999
The potential role of bisphosphonates in prostate cancer
2002
Alendronate inhalation ameliorates elastase-induced pulmonary emphysema in mice by induction of apoptosis of alveolar macrophages
2015
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
The TRAF Family of Signal Transducers Mediates NF-κB Activation by the TRANCE Receptor
1998 StandoutNobel
Parathyroid Hormone-Related Protein Production by Breast Cancers, Improved Survival, and Reduced Bone Metastases
2001
Targeted delivery to bone and mineral deposits using bisphosphonate ligands
2015
Theoretical perspective: A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates
1996
Expression of Bone Extracellular Matrix Proteins on Osteoblast Cells in the Presence of Mineral Trioxide
2007
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Osteoblast Programmed Cell Death (Apoptosis): Modulation by Growth Factors and Cytokines
1998
The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases.
2001
Bone Resorption by Osteoclasts
2000 StandoutScience
Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
2001
Recent advances in bone-targeting nanoparticles for biomedical applications
2021
Increased Adipogenesis and Myelopoiesis in the Bone Marrow of SAMP6, a Murine Model of Defective Osteoblastogenesis and Low Turnover Osteopenia
1997
Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects
2003 Standout
Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice.
2002
Bisphosphonate treatment inhibits the growth of prostate cancer cells.
2001
A Bone-Seeking Clone Exhibits Different Biological Properties from the MDA-MB-231 Parental Human Breast Cancer Cells and a Brain-Seeking Clone In Vivo and In Vitro
2001
Estrogen Receptor-α Is Developmentally Regulated during Osteoblast Differentiation and Contributes to Selective Responsiveness of Gene Expression
1998
Bisphosphonates in prostate carcinoma
1997
Regulation of Osteoclast Function
1997
Mechanisms of Estrogen Action
2001 Standout
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model
2006
Differential Expression of Bone Matrix Regulatory Proteins in Human Atherosclerotic Plaques
2001
Systemic Administration of Acidic Fibroblast Growth Factor (FGF-1) Prevents Bone Loss and Increases New Bone Formation in Ovariectomized Rats
1999
Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases.
2000
Adjuvant Clodronate Treatment Does Not Reduce the Frequency of Skeletal Metastases in Node-Positive Breast Cancer Patients: 5-Year Results of a Randomized Controlled Trial
2001
NF-κB p50 and p52 Expression Is Not Required for RANK-Expressing Osteoclast Progenitor Formation but Is Essential for RANK- and Cytokine-Mediated Osteoclastogenesis
2002
Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis.
2001
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Clinical Assessment of Mineral Trioxide Aggregate (MTA) as Direct Pulp Capping in Young Permanent Teeth
2007
Multiple Myeloma
2011 Standout
The Heat Shock Protein 90 Inhibitor, 17-Allylamino-17-demethoxygeldanamycin, Enhances Osteoclast Formation and Potentiates Bone Metastasis of a Human Breast Cancer Cell Line
2005
Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: Variations in yield, growth, and differentiation
1999
Systemic Administration of Insulin-Like Growth Factor (IGF)-Binding Protein-4 (IGFBP-4) Increases Bone Formation Parameters in Mice by Increasing IGF Bioavailability via an IGFBP-4 Protease-Dependent Mechanism*
2001
Vascular Calcification
2008 Standout
Molecular mechanisms of cancer pain
2002
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Anti-α4 integrin antibody suppresses the development of multiple myeloma and associated osteoclastic osteolysis
2004
The two faces of transforming growth factor β in carcinogenesis
2003 Standout
Bisphosphonates: Mechanisms of Action
1998
Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro
1999
Works of Kenneth R. Wright being referenced
Identification of Hard Tissue After Experimental Pulp Capping Using Dentin Sialoprotein (DSP) as a Marker
2003
The effects of cytokines and growth factors on osteoblastic cells
1995
Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
1995
Recent advances in bone biology provide insight into the pathogenesis of bone diseases.
1999
Targeting simian virus 40 T antigen to the osteoclast in transgenic mice causes osteoclast tumors and transformation and apoptosis of osteoclasts.
1995
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
1995
Osteoclast Formation in Bone Marrow Cultures from Two Inbred Strains of Mice with Different Bone Densities
1999